美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0054-0255-22	0054-0255	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide	Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20121015	N/A	ANDA	ANDA090351	Hikma Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5 mg/1; 300 mg/1	90 TABLET in 1 BOTTLE (0054-0255-22)
0054-0255-13	0054-0255	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide	Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20121015	N/A	ANDA	ANDA090351	Hikma Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5 mg/1; 300 mg/1	30 TABLET in 1 BOTTLE (0054-0255-13)
0054-0254-22	0054-0254	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide	Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20121015	N/A	ANDA	ANDA090351	Hikma Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5 mg/1; 150 mg/1	90 TABLET in 1 BOTTLE (0054-0254-22)
0054-0254-13	0054-0254	HUMAN PRESCRIPTION DRUG	Irbesartan and Hydrochlorothiazide	Irbesartan and Hydrochlorothiazide	TABLET	ORAL	20121015	N/A	ANDA	ANDA090351	Hikma Pharmaceuticals USA Inc.	HYDROCHLOROTHIAZIDE; IRBESARTAN	12.5 mg/1; 150 mg/1	30 TABLET in 1 BOTTLE (0054-0254-13)